Dr. Andrea Fischer

General neurologist · Osaka University Hospital · Japan (JP) · Neurology

Tier 2STK-0141GoodOwner MSL LOLuis Ortega

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Headache medicine
Disease interests: MIG
Scientific interests: Chronic migraineMedication-overuse headacheSwitching
Engagement preference: Virtual
Advisory boards: 0
Publications: 59
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 25 Apr 2026 (143 days ago)
Next planned contact: 25 Oct 2026
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
25 Apr 2026	Scientific exchange	Virtual	Luis Ortega	Lumeva	Real-world persistence	0	—	Reviewed	ENG-0189
04 Jan 2026	Medical education	Phone	Luis Ortega	Lumeva	Dosing in hepatic impairmentDrug interactions+1	0	—	Reviewed	ENG-0173

Timeline

25 Apr 2026
Scientific exchange
Real-world persistence
04 Jan 2026
Medical education
Dosing in hepatic impairment, Drug interactions, Switching between CGRP agents

Related stakeholders (9)

Osaka University Hospital

Dr. Javier Weber
Pathologist
Tier 3
Dr. Noor Dubois
Thoracic medical oncologist
Tier 3
Dr. Yuki Quinn
Thoracic medical oncologist
Tier 2
Dr. Tomoko Ueda
Pathologist
Tier 2
Dr. Ximena Rossi
Radiation oncologist
Tier 1
Dr. Benedikt Ivanova
Oncology pharmacist
Tier 2
Dr. Chloé Dubois
Pathologist
Tier 3
Dr. Farah Jensen
Primary care physician
Tier 1
Dr. Ximena Bauer
General neurologist
Tier 3